Table 1.
Part 1: Criteria for inclusion of clinical trials in PEDro (all criteria must be fulfilled) | |
| |
Part 2: Assessment criteria of clinical trials included in PEDro | |
No. | Assessment criterion |
1a | Eligibility criteria were specified. |
2 | Subjects were randomly allocated to groups. |
3 | Allocation was concealed. |
4 | The groups were similar at baseline regarding the most important prognostic indicators. |
5 | There was blinding of all subjects. |
6 | There was blinding of all therapists who administered the therapy. |
7 | There was blinding of all assessors who measured at least one key outcome. |
8 | Measures of at least one key outcome were obtained from >85% of the subjects initially allocated to groups. |
9 | All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome were analysed by ‘intention to treat’. |
10 | The results of between-group statistical comparisons are reported for at least one key outcome. |
11 | The study provides both point measures and measures of variability for at least one key outcome. |
aThis criterion influences external validity, but not the internal or statistical validity of the trial. It has been included in the PEDro scale so that all items of the Delphi scale9 are represented on the PEDro scale. This item is not used to calculate the PEDro score.